BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 36931504)

  • 1. Institution-Level Evolution of Lung Cancer Resection Quality With Implementation of a Lymph Node Specimen Collection Kit.
    Akinbobola O; Ray MA; Fehnel C; Saulsberry A; Dortch K; Smeltzer M; Faris NR; Osarogiagbon RU
    J Thorac Oncol; 2023 Jul; 18(7):858-868. PubMed ID: 36931504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative Effectiveness of a Lymph Node Collection Kit Versus Heightened Awareness on Lung Cancer Surgery Quality and Outcomes.
    Ray MA; Fehnel C; Akinbobola O; Faris NR; Taylor M; Pacheco A; Smeltzer MP; Osarogiagbon RU
    J Thorac Oncol; 2021 May; 16(5):774-783. PubMed ID: 33588112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes After Use of a Lymph Node Collection Kit for Lung Cancer Surgery: A Pragmatic, Population-Based, Multi-Institutional, Staggered Implementation Study.
    Osarogiagbon RU; Smeltzer MP; Faris NR; Ray MA; Fehnel C; Ojeabulu P; Akinbobola O; Meadows-Taylor M; McHugh LM; Halal AM; Levy P; Sachdev V; Talton D; Wiggins L; Shu XO; Shyr Y; Robbins ET; Klesges LM
    J Thorac Oncol; 2021 Apr; 16(4):630-642. PubMed ID: 33607311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of Implemented Interventions on Pathologic Nodal Staging of Non-Small Cell Lung Cancer.
    Ray MA; Faris NR; Smeltzer MP; Fehnel C; Houston-Harris C; Levy P; Wiggins L; Sachdev V; Robbins T; Spencer D; Osarogiagbon RU
    Ann Thorac Surg; 2018 Jul; 106(1):228-234. PubMed ID: 29534956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two Interventions on Pathologic Nodal Staging in a Population-Based Lung Cancer Resection Cohort.
    Osarogiagbon RU; Ray MA; Fehnel C; Akinbobola O; Saulsberry A; Dortch K; Faris NR; Matthews AT; Smeltzer MP; Spencer D;
    Ann Thorac Surg; 2024 Mar; 117(3):576-584. PubMed ID: 37678613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Pathologic Nodal Staging Quality With Survival Among Patients With Non-Small Cell Lung Cancer After Resection With Curative Intent.
    Smeltzer MP; Faris NR; Ray MA; Osarogiagbon RU
    JAMA Oncol; 2018 Jan; 4(1):80-87. PubMed ID: 28973110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of a surgical specimen-collection kit to improve mediastinal lymph-node examination of resectable lung cancer.
    Osarogiagbon RU; Miller LE; Ramirez RA; Wang CG; O'Brien TF; Yu X; Khandekar A; Schoettle GP; Robbins SG; Robbins ET; Gibson JB
    J Thorac Oncol; 2012 Aug; 7(8):1276-82. PubMed ID: 22653076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonexamination of lymph nodes and survival after resection of non-small cell lung cancer.
    Osarogiagbon RU; Yu X
    Ann Thorac Surg; 2013 Oct; 96(4):1178-1189. PubMed ID: 23910633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In Response: Taichiro Goto "Kit Use May Not Be Key To Improved Prognosis"; Response to "Akinbobola O, Ray MA, Fehnel C, et al. Institution-Level Evolution of Lung Cancer Resection Quality With Implementation of a Lymph Node Specimen Collection Kit".
    Akinbobola O; Ray MA; Smeltzer MP; Osarogiagbon RU
    J Thorac Oncol; 2023 Aug; 18(8):e80-e81. PubMed ID: 37479331
    [No Abstract]   [Full Text] [Related]  

  • 10. Invasive mediastinal staging for resected non-small cell lung cancer in a population-based cohort.
    Osarogiagbon RU; Lee YS; Faris NR; Ray MA; Ojeabulu PO; Smeltzer MP
    J Thorac Cardiovasc Surg; 2019 Oct; 158(4):1220-1229.e2. PubMed ID: 31147169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathologic lymph node staging practice and stage-predicted survival after resection of lung cancer.
    Osarogiagbon RU; Allen JW; Farooq A; Berry A; O'Brien T
    Ann Thorac Surg; 2011 May; 91(5):1486-92. PubMed ID: 21524460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of Updated Commission on Cancer Guidelines for Intraoperative Lymph Node Sampling in Early Stage NSCLC.
    Heiden BT; Eaton DB; Chang SH; Yan Y; Schoen MW; Patel MR; Kreisel D; Nava RG; Meyers BF; Kozower BD; Puri V
    J Thorac Oncol; 2022 Nov; 17(11):1287-1296. PubMed ID: 36049657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Completeness of lung cancer surgery: is mediastinal dissection common practice?
    Verhagen AF; Schoenmakers MC; Barendregt W; Smit H; van Boven WJ; Looijen M; van der Heijden EH; van Swieten HA
    Eur J Cardiothorac Surg; 2012 Apr; 41(4):834-8. PubMed ID: 22290900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A standardized technique of systematic mediastinal lymph node dissection by video-assisted thoracoscopic surgery (VATS) leads to a high rate of nodal upstaging in early-stage non-small cell lung cancer.
    Reichert M; Steiner D; Kerber S; Bender J; Pösentrup B; Hecker A; Bodner J
    Surg Endosc; 2016 Mar; 30(3):1119-25. PubMed ID: 26169635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Value of National Comprehensive Cancer Network Lung Cancer Resection Quality Criteria.
    Osarogiagbon RU; Ray MA; Faris NR; Smeltzer MP; Fehnel C; Houston-Harris C; Signore RS; McHugh LM; Levy P; Wiggins L; Sachdev V; Robbins ET
    Ann Thorac Surg; 2017 May; 103(5):1557-1565. PubMed ID: 28366464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mediastinoscopy might not be necessary in patients with non-small cell lung cancer with mediastinal lymph nodes having a maximum standardized uptake value of less than 5.3.
    Lee BE; Redwine J; Foster C; Abella E; Lown T; Lau D; Follette D
    J Thorac Cardiovasc Surg; 2008 Mar; 135(3):615-9. PubMed ID: 18329480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the number of lymph nodes examined on the survival of patients with stage I non-small cell lung cancer who undergo sublobar resection.
    Yendamuri S; Dhillon SS; Groman A; Dy G; Dexter E; Picone A; Nwogu C; Demmy T; Hennon M
    J Thorac Cardiovasc Surg; 2018 Jul; 156(1):394-402. PubMed ID: 29709364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival and Resected Lymph Node Number During Sublobar Resection for N0 Non-Small Cell Lung Cancer 2 cm or Less.
    Ding H; Wang H; Xu L; Song N; Jiang G
    Ann Thorac Surg; 2019 Jun; 107(6):1647-1655. PubMed ID: 30682353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Institutional-Level Differences in Quality and Outcomes of Lung Cancer Resections in the United States.
    Osarogiagbon RU; Sineshaw HM; Lin CC; Jemal A
    Chest; 2021 Apr; 159(4):1630-1641. PubMed ID: 33197400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymph Node Yield in Lung Cancer Resection is Associated With Demographic and Institutional Factors.
    Sarnaik KS; Bassiri A; Poston LM; Gasnick A; Sinopoli JN; Tapias Vargas L; Linden PA; Towe CW
    J Surg Res; 2024 Jan; 293():175-186. PubMed ID: 37776720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.